आईएसएसएन: 2157-2526

जैवआतंकवाद और जैवरक्षा जर्नल

खुला एक्सेस

हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।

ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं

में अनुक्रमित
  • CAS स्रोत सूचकांक (CASSI)
  • सूचकांक कॉपरनिकस
  • गूगल ज्ञानी
  • शेरपा रोमियो
  • जे गेट खोलो
  • जेनेमिक्स जर्नलसीक
  • शैक्षणिक कुंजी
  • जर्नल टीओसी
  • अनुसंधान बाइबिल
  • चीन राष्ट्रीय ज्ञान अवसंरचना (सीएनकेआई)
  • उलरिच की आवधिक निर्देशिका
  • RefSeek
  • हमदर्द विश्वविद्यालय
  • ईबीएससीओ एज़
  • ओसीएलसी- वर्ल्डकैट
  • एसडब्ल्यूबी ऑनलाइन कैटलॉग
  • पबलोन्स
  • चिकित्सा शिक्षा और अनुसंधान के लिए जिनेवा फाउंडेशन
  • यूरो पब
  • आईसीएमजेई
इस पृष्ठ को साझा करें


Statistical Analysis on Alzheimer's Disease

Min Zhao

Alzheimer's disease is a progressive neurodegenerative disease that occurs mostly in the elderly and has memory impairment as the main clinical symptom. There is no ideal treatment for Alzheimer's disease, so early prevention is important. In this paper, we use brain structural information to diagnose Alzheimer's disease features and cognitivebehavioral characteristics, which is important for early and accurate diagnosis of mild cognitive impairment. To investigate the factors influencing Alzheimer's disease, a correlation analysis model was developed after preprocessing the missing values of the data. First, the data features were viewed, the missing values of the data were analyzed, and the useless features were removed and the missing values of the remaining features were filled with the average value. To verify the accuracy of the subsequent intelligent diagnosis model and clustering model, this paper divides the training set and test set according to PTID. Finally, the top ten important features are selected and the Spearman coefficients are chosen according to the distribution of the features for correlation analysis. Machine learning methods were utilized to build an Alzheimer's classification model to solve the problem of intelligent diagnosis of Alzheimer's disease. The pre-processed dataset in the above paper was trained with the model, and five methods of logistic regression, support vector machine, KNN classification, decision tree classification and XGB were utilized to build the classification model, and the accuracy, recall and F1 value of each model were visualized and compared, among which the accuracy of XGB model reached 83%, which is reasonable for the intelligent diagnosis of the disease. A K-Meansbased clustering model for disease types was established using the K-Means clustering algorithm, clustering CN, MCI and AD into three major classes, and then refining MCI into three subclasses. The optimal K-values and random seeds were firstly found using the elbow principle, then the cluster analysis was performed using the feature values and data sets selected after preprocessing, and finally the MCI in MCI was extracted and sub-clustered into three subclasses SMC, EMCI and LMCI. In order to investigate the evolution pattern of different categories of diseases over time, patients with 3 categories of diseases are screened separately for analysis in this paper. Firstly, by combining the results above and reviewing the data, the features irrelevant to this task and columns containing a large number of missing values were removed, the remaining features were selected and probability density plots were drawn, and all discrete features and all features that were essentially zero were continued to be screened out. After that, the 15 features of CN, MCI and AD diseases were plotted separately over time to reveal their evolution patterns over time. We reviewed the relevant literature, sorted out and summarized the existing studies at home and abroad, and summarized the criteria for determining the five stages of Alzheimer's disease and the early intervention of the disease.